ARTICLE | Clinical News
Teriparatide: Phase I started
February 1, 2010 8:00 AM UTC
Zelos began a Phase I trial to compare an intranasal formulation of ZT-034 vs. injectable Forteo teriparatide for 7 days in 50 healthy postmenopausal women. Zelos developed the intranasal formulation...